戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 remains a treatment solution for molars with furcation defects.
2 emonstrated histologically in human Class II furcation defects.
3 mbrane in the healing of mandibular Class II furcation defects.
4 ported to enhance bone regeneration of molar furcation defects.
5 llografts (DFDBA) in Class II buccal/lingual furcation defects.
6 iagnosis and treatment of both intrabony and furcation defects.
7  use of bone or bone substitutes on Class II furcation defects.
8 edure, a resin-ionomer was placed into all 3 furcation defects.
9 cal or lingual, or maxillary buccal Class II furcation defects.
10  debridement alone in human mandibular molar furcation defects.
11 ditioning for the treatment of intrabony and furcation defects.
12 l antibiotics on osseous healing in Class II furcation defects.
13 tically superior osseous healing of Class II furcation defects.
14 done for both intrabony defects and Class II furcation defects.
15 n surgically created critical size Class III furcation defects.
16 al and radiographic evidence of intrabony or furcation defects.
17 on (GTR) for the correction of intrabony and furcation defects.
18 yzed-seven infrabony, six suprabony, and six furcation defects.
19 ation of CBCT for diagnosis of intrabony and furcation defects.
20 root planing (SRP) for treatment of Class II furcation defects.
21  a regenerative material in the treatment of furcation defects.
22 ve been tried and tested in the treatment of furcation defects.
23 d/or treatment planning for intrabony and/or furcation defects.
24  and/or treatment planning for intrabony and furcation defects.
25 al and mandibular facial or lingual Class II furcation defects.
26 ed a viable treatment option for molars with furcation defects.
27  on the topic of periodontal regeneration of furcation defects.
28 eported outcomes after surgical treatment of furcation defects.
29 ) and PRF alone in the treatment of grade II furcation defects.
30 e on the outcomes of regenerative therapy in furcation defects.
31  healing of human mandibular buccal Class II furcation defects.
32 can provide a new direction in management of furcation defects.
33  patients with 10 mandibular Class II buccal furcation defects.
34 e and supports osseous regrowth in degree II furcation defects.
35  planing (SRP) for the treatment of Class II furcation defects.
36  use of BG in the treatment of intrabony and furcation defects.
37 ppropriate for the treatment of intrabony or furcation defects.
38 ne, for the treatment of mandibular class II furcation defects.
39 ound healing in surgically created Class III furcation defects.
40 ular molars to achieve Class III, subclass C furcation defects.
41 ce treatment outcomes in mandibular Class II furcation defects.
42 tly improve bone fill in mandibular Class II furcation defects.
43                              Of the residual furcation defects, 68% were reduced to Class I.
44 le regenerative outcomes in the treatment of furcation defects, adverse systemic and local factors sh
45 rapeutic option for the treatment of various furcation defects, among which Class II defects represen
46 guided tissue regeneration (GTR) in Class II furcation defects and establish the factors that might b
47 f CBCT for the detection of intrabony and/or furcation defects and how CBCT influenced the diagnosis
48 of regenerative therapy for the treatment of furcation defects and recommendations for future researc
49 guidelines for the therapeutic management of furcation defects and to identify priorities for future
50 d in generally favorable clinical results in furcation defects, appeared to be better than DEBR alone
51 regenerative therapy for maxillary Class III furcation defects are limited to clinical case reports.
52 ted risk factors that could lead to isolated furcation defects around molar teeth.
53 TV group in treatment of mandibular Class II furcation defects as an adjunct to SRP.
54 views some of the studies on regeneration in furcation defects as well as some of the uniqueness and
55 s and reentry documentation suggest that the furcation defect associated with poor biologic width was
56                    Plaque was collected from furcation defects at baseline and 3 and 6 months post-tr
57 d mesial of the fourth premolar and Class II furcation defects at the buccal furcation of the mandibu
58 e-height loss in interproximal intrabony and furcation defects, but the length of new cementum in the
59  for the diagnosis of Class II and Class III furcation defects by clinical probing.
60 e, while diagnostic aspects of intrabony and furcation defects can be improved via the use of CBCT, l
61  PRF over PRF alone in treatment of Grade II furcation defects, clinically and radiographically by us
62 h fibrin (PRF) and PRF alone in treatment of furcation defects, clinically and radiographically using
63 he surgical treatment of mandibular Class II furcation defects compared with autologous PRF and HA bo
64 regenerative approaches for the treatment of furcation defects compared with conventional surgical th
65 ised in the area being treated, the bone and furcation defects debrided of granulomatous tissue, and
66                 Following flap elevation and furcation defect debridement, an occlusal reference sten
67 tions will give more reduction in horizontal furcation defect depth compared with resorbable membrane
68 ments to evaluate regenerative procedures in furcation defects do not seem to be used as yet.
69 t, were more likely to have greater vertical furcation defect fill than the conventional OFD surgery.
70 ce of two or more mandibular facial Class II furcation defects (> or = 3 mm horizontal probing depth)
71 l, and mandibular facial or lingual Class II furcation defects has been demonstrated in several studi
72          Individuals with a single degree II furcation defect in a mandibular molar participated.
73 y subjects with a Class II buccal or lingual furcation defect in lower molars were treated.
74                         Twenty-four Class II furcation defects in 24 patients were treated with eithe
75 ix proteins on the regeneration of Class III furcation defects in baboons.
76 ed using naturally occurring buccal Class II furcation defects in beagle dogs.
77 ve predictable outcomes for the treatment of furcation defects in certain clinical scenarios.
78  planing (SRP) for the treatment of Class II furcation defects in comparison with placebo gel.
79 luded 23 patients with 46 bilateral Grade II furcation defects in first or second maxillary or mandib
80 PCs for the treatment of mandibular Class II furcation defects in humans and to provide data on the a
81 rovement following the treatment of Class II furcation defects in humans.
82 jects with Hamp's Class II buccal or lingual furcation defects in lower molars were randomly assigned
83 es (PTG) in the treatment of Class II buccal furcation defects in mandibular molars in humans.
84 llary molars; 4) facial and lingual Class II furcation defects in mandibular molars; 5) Class III fur
85 on defects in maxillary molars; 6) Class III furcation defects in mandibular molars; and 7) Class I,
86  regenerative therapy in maxillary Class III furcation defects in maxillary molars is limited to clin
87 nes in the healing of interproximal Class II furcation defects in maxillary molars using a surgical t
88 molars; 3) facial and interproximal Class II furcation defects in maxillary molars; 4) facial and lin
89 n defects in mandibular molars; 5) Class III furcation defects in maxillary molars; 6) Class III furc
90 andibular molars; and 7) Class I, II, or III furcation defects in maxillary premolars.
91 ment of surgically created buccal, degree II furcation defects in mini-pigs.
92 regenerative approaches for the treatment of furcation defects in specific clinical scenarios compare
93 regenerative approaches for the treatment of furcation defects in specific clinical scenarios compare
94 otted 21 patients with 42 bilateral Grade II furcation defects into two groups.
95                       Treatment of the molar furcation defect is a challenge to the dental profession
96                                 Treatment of furcation defects is a core component of periodontal the
97 comes of guided tissue regeneration (GTR) in furcation defects is imperative in order to obtain predi
98 robing to distinguish Class II and Class III furcation defects is unknown.
99 in clinical scenarios, although most Class I furcation defects may be successfully treated with non-r
100 inical scenarios, although generally Class I furcation defects may be treated predictably with non-re
101 OFD for the treatment of mandibular Class II furcation defects may lead to slight improvements in cli
102 ent had adult periodontitis and one Class II furcation defect measuring > or = 3 mm open horizontal p
103      Twelve patients with bilateral Class II furcation defects on lower first molars participated in
104 mandibular molars, one of which had Class II furcation defects, received the hygienic phase of therap
105 bioactive glass in the treatment of Class II furcation defects regarding the clinical parameters of p
106                                   In Class I furcation defects, regenerative therapy may be beneficia
107                                4) In Class I furcation defects, regenerative therapy may be beneficia
108    Factors influencing treatment outcomes in furcation defects remain to be studied.
109                Successful treatment of molar furcation defects remains a challenge in clinical practi
110                           Treatment of molar furcation defects remains a considerable challenge in cl
111          However, its effect in regenerating furcation defects remains to be determined.
112               GTR procedure was performed in furcation defect sites using expanded polytetrafluoroeth
113 hat local delivery of 1% ALN into a Class II furcation defect stimulates a significant PD reduction,
114                 Each patient contributed two furcation defects that were treated by combination thera
115                                  In Grade II furcation defects the combination therapy of 1% melatoni
116 acy and outcomes of regenerative therapy for furcation defects, the use of platelet concentrates (PCs
117 y within the periodontal tissues in Grade II furcation defects to a greater extent.
118 ate the clinical response of buccal Class II furcation defects to open-flap debridement (OFD) and to
119                                              Furcation defects treated and followed for at least 1 ye
120                                              Furcation defects treated with GTR using an allogeneic c
121                                  In summary, furcation defects treated with membrane barriers can be
122 mal defects and all evaluable (four of four) furcation defects treated with PDGF.
123                                              Furcation defects treated with rhPDGF/allograft exhibite
124 w is to evaluate whether mandibular Class II furcation defects treated with the addition of PC to OFD
125  ALN gel combination in mandibular degree II furcation defect treatment in comparison with PRF and ac
126                                              Furcation defect treatment with autologous PRF combined
127 orting periodontal structures and tested for furcation defect treatment.
128   In addition, the placement of DFDBA in the furcation defect under the bioabsorbable membrane result
129  and/or treatment planning for intrabony and furcation defects, using a well-known six-tiered hierarc
130 mulated recommendations for the treatment of furcation defects via regenerative therapies and the con
131 enovirus and kidney capsule grafts, the root furcation defect was partially rescued.
132                             The CAL gain for furcation defects was 3.2 +/- 2.17 mm (P < 0.030).
133        A split mouth study with 40 bilateral furcation defects was randomly divided into PRF group an
134 nterproximal intrabony and/or molar Class II furcation defect were entered into the study.
135  Thirteen pairs of mandibular molar Class II furcation defects were evaluated in 13 patients.
136 en adult periodontal patients with Class III furcation defects were evaluated.
137 ter elevation of soft tissue flaps, Class II furcation defects were prepared by removing buccal alveo
138 two patients with mandibular buccal Class II furcation defects were randomized and categorized into t
139            A total of 69 mandibular Class II furcation defects were randomized and treated with eithe
140 ine patients with mandibular Class II buccal furcation defects were randomized to beta-tricalcium-pho
141 ety patients with mandibular buccal Class II furcation defects were randomly allocated to three treat
142 bular molars with buccal or lingual Class II furcation defects were studied.
143                             Buccal degree II furcation defects were surgically created in maxillary p
144                                Intrabony and furcation defects were the two most commonly discussed b
145                 Seventy-two mandibular molar furcation defects were treated with either access therap
146                  One hundred five mandibular furcation defects were treated with OFD + placebo gel (g
147 les (seven infrabony, six suprabony, and six furcation defects) were eligible for sequencing.
148 iting one buccal or lingual mandibular molar furcation defect, were randomly assigned to three treatm
149                                 Treatment of furcation defects with 1.2 mg RSV in situ gel combined w
150 e regeneration (GTR) treating human Class II furcation defects with a new polylactic-acid-based bioab
151 N with PRF has potential for regeneration of furcation defects without any adverse effect on healing

 
Page Top